ATLANTA, Georgia, Dec. 17 -- Alston and Bird, a law firm, issued the following news release: Alston & Bird advised Veritiv Operating Company, a leader in specialty packaging distribution, on the sale of Veritiv Containers, the company's rigid-packaging business, to TricorBraun, a global packaging leader. Pending regulatory approval, the sale is expected to be completed in the first quarter of 2025. Representing Veritiv was an Alston & Bird team led by partners Alison LeVasseur and Justin Howa  more

ATLANTA, Georgia, Dec. 17 -- Alston and Bird, a law firm, issued the following news release: Alston & Bird client Regional Management Corp., a diversified consumer finance company, has closed its eleventh securitization, a private offering of $250 million of asset-backed notes. The securitization has a two-year revolving period, and the Class A notes received a top rating of "AAA" by Standard & Poor's and Morningstar DBRS. Advising Regional Management was an Alston & Bird team led by partner   more

ATLANTA, Georgia, Dec. 17 -- Constangy, Brooks, Smith and Prophete, a law firm, issued the following news release: Constangy is delighted to welcome Katherine Serrano, Eric Witt and Rob Yang to the firm, further strengthening its employment law and cybersecurity practices. A skilled litigator based in Constangy's Austin office, Katherine Serrano brings extensive experience representing employers in complex employment litigation matters. She focuses on wage and hour class and collective actions  more

ATLANTA, Georgia, Dec. 17 (TNSres) -- Alston and Bird, a law firm, issued the following news release: Alston & Bird senior counsel Larry Gage recently published a report co-authored with A&M Managing Director Mark Finucane with their findings that highlight the intricate dynamics of nonprofit health system governance. This report, based on a survey of 17 high-performing nonprofit hospital systems, examines evolving challenges for health system boards, explores governance models, and offers evid  more

ITHACA, New York, Dec. 16 -- Cornell University issued the following news: A Cornell professor's election forecasting model correctly picked Trump's win this year in all 50 states and would have correctly predicted 95% of states in every election since 2000. The model was developed by Peter Enns, professor of government in the College of Arts and Sciences and professor in the Cornell Jeb E. Brooks School of Public Policy, along with Julius Lagodny, Ph.D. '22, and was first deployed in the 2020  more

ATLANTA, Georgia, Dec. 17 -- Troutman Pepper, a law firm, issued the following news: * * * Experienced Real Estate Finance Attorney Enhances Firm's Finance and Restructuring Practice * * * NEW YORK - Stephen Schweiger, a prominent real estate finance attorney, has joined Troutman Pepper's New York office as a partner in the firm's Finance and Restructuring Practice. He joins the firm from Goulston & Storrs. "Stephen's arrival significantly bolsters our Real Estate Finance offerings in New Y  more

FAYETTEVILLE, Georgia, Dec. 17 -- Piedmont issued the following news release: Stockbridge, Ga. (December 16, 2024) - Thomas Dellavalle was gathering his family to leave town ahead of Hurricane Milton. When he took an awkward lunge to remove his dog from a scuffle, he knew something was wrong immediately. "It felt like I got shot," Dellavalle said. "The pain was in my calf and it felt like it had exploded." The family started the trek up I-75 at the same time as many other Florida residents. W  more

ATLANTA, Georgia, Dec. 17 -- Troutman Pepper, a law firm, issued the following news: WASHINGTON D.C. -- Troutman Pepper was pleased to represent the syndicate of underwriters, with such syndicate co-lead by Raymond James Limited and Lake Street Capital Partners, in Profound Medical Corp.'s (TSX: PRN; NASDAQ: PROF) recently closed US$40.25 million underwritten public offering of common shares at a public offering price of US$7.50 per common share. For more about Profound's recent offering, read   more

ATLANTA, Georgia, Dec. 17 (TNSres) -- Emory University Winship Cancer Institute issued the following news release: The U.S. Food and Drug Administration (FDA) has approved obecabtagene autoleucel (Aucatzyl, Autolus Inc.) for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), a fast-growing blood cancer that starts in the bone marrow and affects the body's ability to fight infection. The approval follows results of a landmark study, published in The New Engla  more